financetom
Business
financetom
/
Business
/
Data security firm Radware Q2 revenue beats estimates 
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Data security firm Radware Q2 revenue beats estimates 
Jul 30, 2025 3:26 AM

Overview

* Radware Q2 2025 revenue grows 10% yr/yr, beating analyst expectations

* Non-GAAP diluted EPS for Q2 rises to $0.28 from $0.20

* Cloud ARR increases 21% yr/yr, driven by cloud security focus

Outlook

* Radware ( RDWR ) focuses on cloud security as primary growth engine

* Company expanding partnerships and advancing AI innovation

Result Drivers

* CLOUD SECURITY FOCUS - Radware ( RDWR ) attributes strong Q2 performance to focus on cloud security as primary growth engine, per CEO Roy Zisapel

* AI INNOVATION - Advancements in AI innovation cited as factor strengthening competitive leadership

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Beat $74.22 $73.50

Revenue mln mln (4

Analysts

)

Q2 Net $4.22

Income mln

Q2 Gross $59.90

Profit mln

Q2 $2.80

Operatin mln

g Income

Q2 $6.46

Pretax mln

Profit

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the software peer group is "buy"

* Wall Street's median 12-month price target for Radware Ltd ( RDWR ) is $30.00, about 5.6% above its July 29 closing price of $28.33

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Novartis plans to invest $23 billion in US plants as Trump renews drug tariff threats
Novartis plans to invest $23 billion in US plants as Trump renews drug tariff threats
Apr 10, 2025
(Reuters) -Swiss drugmaker Novartis said on Thursday it plans to spend $23 billion to build and expand 10 facilities in the U.S., as it grapples with renewed threats of drug import duties from the Trump administration. The drugmaker plans to build six new manufacturing plants, some of which will make raw pharmaceutical ingredients, as well as a new research and...
EV maker Polestar lures disgruntled Tesla owners with discounts
EV maker Polestar lures disgruntled Tesla owners with discounts
Apr 10, 2025
* Polestar targets Tesla owners with big discount strategy * Campaign may lure Tesla customers disgruntled with Musk * Polestar 3 price drops to $73,000 for Tesla owners with discount (Adds comment from company executive in paragraph 2, recasts paragraph 1) By Zaheer Kachwala and Marie Mannes April 10 (Reuters) - Nearly half of Polestar's global sales in the quarter...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Capri aims to revive Michael Kors with lower prices, Amazon e-commerce sales
Capri aims to revive Michael Kors with lower prices, Amazon e-commerce sales
Apr 10, 2025
(Reuters) - Capri Holdings ( CPRI ) may have to let go of its image as a luxury fashion house and bank on mid-tier pricing as well as a partnership with Amazon.com ( AMZN ) for its Michael Kors brand following its $1.4 billion sale of Versace to Prada. After Italy's Prada struck a deal to buy smaller rival Versace...
Copyright 2023-2026 - www.financetom.com All Rights Reserved